Novel therapeutic approach to slow down the inflammatory cascade in acute/subacute spinal cord injury: Early immune therapy with lipopolysaccharide enhanced neuroprotective effect of combinational therapy of granulocyte colony-stimulating factor and bone-marrow mesenchymal stem cell in spinal cord injury

Bone-marrow mesenchymal stem cells (BM-MSCs) have not yet proven any significant therapeutic efficacy in spinal cord injury (SCI) clinical trials, due to the hostile microenvironment of the injured spinal cord at the acute phase. This study aims to modulate the inflammatory milieu by lipopolysacchar...

Descripción completa

Detalles Bibliográficos
Autores principales: Hashemizadeh, Shiva, Hosseindoost, Saereh, Omidi, Ameneh, Aminianfar, Hossein, Ebrahimi-Barough, Somayeh, Ai, Jafar, Arjmand, Babak, Hadjighassem, Mahmoudreza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cellular Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727083/
https://www.ncbi.nlm.nih.gov/pubmed/36505513
http://dx.doi.org/10.3389/fncel.2022.993019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727083/
https://www.ncbi.nlm.nih.gov/pubmed/36505513
http://dx.doi.org/10.3389/fncel.2022.993019

Ejemplares similares